Jane Street’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Jane Street’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-15,254	Closed	-$13K	–	3385
2014 Q3	$13K	Sell	15,254 -9,490	-38%	-$17.1K	﹤0.01%	2479
2014 Q2	$56K	Buy	+24,744	New	+$61.5K	﹤0.01%	2419
2014 Q1	–	Sell	-14,740	Closed	-$46K	–	3322
2013 Q4	$46K	Buy	+14,740	New	+$41.1K	﹤0.01%	2241

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NPC

National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Jane Street's ECTE Position: Q4 2014 in Review

Jane Street sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q4 2014, closing a stake of 15,254 shares — an estimated $13K sold.

Jane Street first reported a position in ECTE in Q4 2013 and held it in 3 quarters. The position peaked at $56K in Q2 2014. 17 funds tracked by Wall St. Rank hold ECTE as of Q4 2014.

Jane Street reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q4 2014 after selling out during the quarter.
Jane Street sold 15,254 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q4 2014, an estimated $13K.
Jane Street first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and held it in 3 quarters.
Jane Street's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $56K in Q2 2014.
17 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2014.

Based on Jane Street's 13F filing for Q4 2014, filed 17 Feb 2015.